Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cells

Metformin, which is a drug commonly prescribed to treat type 2 diabetes, has anti-proliferative effects in cancer cells; however, the molecular mechanisms underlying this effect remain largely unknown. The aim is to investigate the role of tristetraprolin (TTP), an AU-rich element-binding protein, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandiri, Indira, Chen, Yingqing, Joe, Yeonsoo, Kim, Hyo Jeong, Park, Jeongmin, Chung, Hun Taeg, Park, Jeong Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788686/
https://www.ncbi.nlm.nih.gov/pubmed/26956973
http://dx.doi.org/10.1007/s10549-016-3742-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788686/
https://www.ncbi.nlm.nih.gov/pubmed/26956973
http://dx.doi.org/10.1007/s10549-016-3742-y

Ejemplares similares